In their new study, released online in the peer-reviewed journal Nature, low-density lipoprotein receptor-related protein 1 (LRP1) was linked to the uptake and spread of tau in the brain.
The future of Alzheimer's disease treatment might be centered more on degeneration correlated with tau protein than beta-amyloid plaques, new research suggests.